Urology
 |
|
10 december 2019 03:03:30 |
| Hereditary Leiomyomatosis and Renal Cell Cancer: Clinical, Molecular, and Screening Features in a Cohort of 185 Affected Individuals (European Urology Oncology) |
|
Tweet Hereditary leiomyomatosis and renal cell cancer (HLRCC) is associated with a 21% lifetime risk of renal cell carcinoma (RCC). We show that renal imaging screening detects early-stage RCC. We recommend annual renal screening in individuals with HLRCC commencing at age 10 yr. |
| 258 viewsCategory: Oncology, Urology |
 Defining the Most Informative Intermediate Clinical Endpoints for Patients Treated with Salvage Radiotherapy for Prostate-specific Antigen Rise After Radical Prostatectomy (European Urology Oncology)Active Surveillance Doing Well Under Surveillance (European Urology Oncology) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page